Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.41
-0.0900-1.64%
Pre-market: 5.440.0310+0.57%07:14 EDT
Volume:13.54M
Turnover:73.40M
Market Cap:2.18B
PE:-3.20
High:5.65
Open:5.35
Low:5.28
Close:5.50
Loading ...
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jun 27, 2024

Proposed Sale Of Securities

Form144 | Recursion Pharmaceuticals' Officer Tina Marriott proposes to sell 6000 Shares, with a total value of approximately $43290.
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Proposed Sale Of Securities

Form144|Recursion Pharmaceuticals' Director Blake Borgeson proposes to sell 11447 Shares, with a total value of approximately $1.09 Million.
Jun 24, 2024

Major Issues Report

Form 8-K - Current report